Evaluate the effect of KRN23 therapy in improving rickets in children with XLH compared with active control oral phosphateactive vitamin D
Data and Resources
- A Randomized Open-Label Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients with X-linked Hypophosphatemia XLHjson
Evaluate the effect of KRN23 therapy in improving rickets in children with...
|Release Date|| |
License Not Specified
|Public Access Level|| |